Can Novo’s Oral Semaglutide Shake Up Indian Diabetes Segment?

 
• By Anju Ghangurde
  
diabetes
Can oral semaglutide disrupt the Indian market? • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia